| α-Syn | α-Synuclein |
| Aβ | Amyloid beta |
| AβPP | Amyloid-beta precursor protein |
| AD | Alzheimer’s disease |
| ALS | Amyotrophic lateral sclerosis |
| ALSFRS-R | Revised amyotrophic lateral sclerosis functional rating scale |
| APP | Amyloid precursor protein |
| AR | Adenosine receptor |
| ATP | Adenosine triphosphate |
| AV | Atrioventricular |
| BACE1 | β-secretase 1 |
| BBB | Blood brain barrier |
| BDNF | Brain-derived neurotrophic factor |
| BFCN | Basal forebrain cholinergic neurons |
| C9orf72 | Chromosome 9 open reading frame 72 |
| CCH | Chronic cerebral hypoperfusion |
| CCL | C-C motif chemokine ligand |
| CLEC7A | C-Type lectin domain containing 7A |
| CNS | Central nervous system |
| COPD | Chronic obstructive pulmonary disease |
| CREB | cAMP response element-binding protein |
| DAMP | Danger-associated molecular pattern |
| DNA | Deoxyribonucleic acid |
| EL | Extracellular loop |
| ERK | Extracellular regulated kinase |
| FDA | Food and drug administration |
| FUS | Fused in Sarcoma, also called translocated in liposarcoma protein (TLP) |
| GABA | Gamma-aminobutyric acid |
| GLT-1 | Glutamate transporter 1 |
| GPCR | G protein-coupled receptor |
| H1 | Histamine 1 |
| HD | Huntington’s disease |
| IFN | Interferon |
| IL | Interleukin |
| JAK | Janus kinase- |
| JNK | C-Jun N-terminal kinase |
| KO | Knock out |
| L-DOPA | Levo-dioxyphenylalanine |
| LPS | Lipopolysaccharide |
| LTD | Long term depression |
| LTP | Long term potentiation |
| MAPK | Mitogen activated protein kinase |
| MAO-B | Monoamine oxidase B |
| mGLU5 | Metabotropic glutamate receptor 5 |
| MPI | Myocardial perfusion imaging |
| MS | Multiple sclerosis |
| NADPH | Nicotinamide adenine dinucleotide phosphate |
| NECA | N-ethylcarboxamidoadenosine |
| NF-κB | Nuclear factor kappa B |
| NFT | Neurofibrillary tangle |
| NLRP3 | NOD-, LRR- and pyrin domain-containing protein 3 |
| NMDA | N-methyl-D-aspartate |
| NO | Nitric oxide |
| OGD | Oxygen glucose deprivation |
| PAMP | Pathogen-associated molecular pattern |
| PD | Parkinson’s disease |
| PLC | Phospholipase C |
| PKA | Protein kinase A |
| PKC | Protein kinase C |
| PRR | Pattern-recognition receptors |
| PS1 | Presenilin-1 |
| RNA | Ribonucleic acid; mRNA (messenger RNA) |
| ROS | Reactive oxygen species |
| SAE | Sepsis associated encephalopathy |
| SAP102 | Synapse-associated protein 102 |
| Shh | Sonic hedgehog |
| SN | Subtantia nigra |
| SOD1 | Superoxide dismutase 1 |
| STAT3 | Signal transducer and transcription activator 3 |
| SVT | Supraventricular tachycardia |
| TBI | Traumatic brain injury |
| TDP-43 | Trans activation response DNA binding protein 43 |
| TGF-β | Transforming growth factor β |
| TLR | Toll-like receptor |
| tMCAo | Transient middle cerebral artery occlusion |
| TNF | Tumor necrosis factor |
| TrKB | Tropomyosin receptor kinase B/tyrosine receptor kinase B |
| tPA | Tissue plasminogen activator |
| USA | Unites States of America |
| VEGF | Vascular endothelial growth factor |